GO:0004353 L-glutamate dehydrogenase [NAD(P)+] activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004353 describes the molecular function of L-glutamate dehydrogenase [NAD(P)+] activity, which catalyzes the reversible oxidative deamination of L-glutamate to 2-oxoglutarate and ammonia using NAD+ or NADP+ as cofactor.
• This activity links amino acid catabolism to the tricarboxylic acid (TCA) cycle and to cellular redox balance, because the reaction produces 2-oxoglutarate and reduced pyridine nucleotides.
• The reaction is central to nitrogen handling and to the metabolic fate of glutamate, a major excitatory neurotransmitter and a key anaplerotic substrate.
• Dysregulation of glutamate dehydrogenase activity has been implicated in metabolic and neurological conditions, including Parkinson's disease and glutamate-induced excitotoxicity.
• Astrocytes and other glial cells rely on glutamate dehydrogenase to regulate cerebral blood flow and to buffer extracellular glutamate.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable precise interrogation of GO:0004353 in disease and metabolism research.
Description
L-glutamate dehydrogenase [NAD(P)+] activity (GO:0004353) is a molecular function that catalyzes the reversible conversion of L-glutamate to 2-oxoglutarate and ammonia, with concomitant reduction of NAD(P)+ to NAD(P)H. This reaction sits at the intersection of amino acid metabolism, the TCA cycle, and cellular redox homeostasis, making it a focal point for researchers studying nitrogen balance, energy metabolism, and neurotransmitter regulation. Because 2-oxoglutarate is a key anaplerotic intermediate and a signaling molecule, the enzyme's activity directly influences mitochondrial function and biosynthetic pathways. In the nervous system, glutamate dehydrogenase helps regulate glutamate levels and supports astrocytic control of cerebral blood flow. The enzyme's ability to use either NAD+ or NADP+ as a cofactor allows it to participate in both catabolic and anabolic redox processes, depending on cellular context. Consequently, GO:0004353 is relevant to diverse fields, from neurobiology and cancer metabolism to microbial physiology and metabolic engineering. Understanding its regulation and genetic control is essential for developing targeted experimental models and therapeutic hypotheses.
L-glutamate dehydrogenase [NAD(P)+] activity At A Glance
| GO ID | GO:0004353 |
|---|---|
| GO term | L-glutamate dehydrogenase [NAD(P)+] activity |
| Ontology | molecular_function |
| Synonym | glutamate dehydrogenase (NAD+) activity; glutamic dehydrogenase activity; L-glutamate:NAD(P)+ oxidoreductase (deaminating) |
| Major function | Catalyzes the reversible oxidative deamination of L-glutamate to 2-oxoglutarate and ammonia, using NAD+ or NADP+ as cofactor |
| Reaction | L-glutamate + NAD(P)+ + H2O = 2-oxoglutarate + NH4+ + NAD(P)H + H+ |
| Cofactors | NAD+ or NADP+ (pyridine nucleotide coenzymes) |
| Subcellular context | Typically mitochondrial in eukaryotes, but also found in cytoplasm and other compartments depending on organism |
| Related pathways | Amino acid catabolism, TCA cycle anaplerosis, nitrogen metabolism, redox homeostasis |
What Is GO:0004353?
GO:0004353, L-glutamate dehydrogenase [NAD(P)+] activity, is defined as the catalysis of the reaction: L-glutamate + NAD(P)+ + H2O = 2-oxoglutarate + NH4+ + NAD(P)H + H+. In other words, it is the oxidative deamination of L-glutamate to 2-oxoglutarate and ammonium, using either NAD+ or NADP+ as an electron acceptor. This activity is reversible and can also catalyze reductive amination of 2-oxoglutarate to glutamate under appropriate conditions. The term is a molecular function in the Gene Ontology and is synonymous with glutamate dehydrogenase (NAD+) activity, glutamic dehydrogenase activity, and L-glutamate:NAD(P)+ oxidoreductase (deaminating).
Why Is L-glutamate dehydrogenase [NAD(P)+] activity Important in Cell Biology?
GO:0004353 is important because it governs a central metabolic node that connects amino acid breakdown to energy production and redox balance. By converting glutamate to 2-oxoglutarate, it supplies the TCA cycle with an anaplerotic substrate and generates reducing equivalents in the form of NAD(P)H. This activity is critical for nitrogen disposal, for maintaining glutamate homeostasis in the brain, and for supporting astrocytic regulation of cerebral blood flow. Dysregulation of glutamate dehydrogenase has been linked to mitochondrial dysfunction in Parkinson's disease and to glutamate-induced excitotoxicity, making it a target for neuroprotective strategies. In addition, the enzyme's dual cofactor specificity allows it to adapt to varying metabolic demands, which is relevant for cancer metabolism and microbial engineering.
• Links amino acid catabolism to the TCA cycle by producing 2-oxoglutarate, a key anaplerotic intermediate.
• Generates NAD(P)H, thereby influencing cellular redox state and antioxidant capacity.
• Regulates glutamate levels, which is critical for neurotransmission and prevention of excitotoxicity.
• Supports astrocytic control of cerebral blood flow and neurovascular coupling.
• Implicated in mitochondrial dysfunction associated with Parkinson's disease.
• Provides a metabolic checkpoint for nitrogen balance and ammonia detoxification.
• Serves as a model enzyme for studying NAD(P)+-dependent dehydrogenases in microbiology and biotechnology.
• Offers a target for modulating autophagy and cell survival pathways in neurons.
• Enables metabolic reprogramming in cancer and immune cells through 2-oxoglutarate supply.
• Facilitates cross-talk between glutamate, citrate, and malate dehydrogenase in multienzyme complexes.
What Happens During L-glutamate dehydrogenase [NAD(P)+] activity?
Substrate Binding and Oxidative Deamination
In simple terms: The enzyme grabs glutamate and removes its amino group.
The catalytic cycle begins with the binding of L-glutamate and NAD(P)+ to the enzyme active site. The enzyme catalyzes the oxidative deamination of glutamate, removing the amino group as ammonia and transferring electrons to NAD(P)+, forming NAD(P)H. The carbon skeleton is released as 2-oxoglutarate. This step is reversible and represents the core of GO:0004353.
Generation of 2-Oxoglutarate and Ammonia
In simple terms: The reaction produces a TCA cycle intermediate and a waste nitrogen molecule.
The products of the forward reaction are 2-oxoglutarate, ammonia (NH4+), and NAD(P)H. 2-Oxoglutarate can enter the TCA cycle for energy production or serve as a precursor for glutamate synthesis via reductive amination. Ammonia is either assimilated into urea or excreted, depending on the organism. This dual output makes the enzyme a hub for carbon and nitrogen metabolism.
Redox Coupling and Cofactor Specificity
In simple terms: The enzyme uses either NAD+ or NADP+ to carry electrons, adapting to the cell's needs.
The [NAD(P)+] designation indicates that the enzyme can utilize both NAD+ and NADP+ as cofactors. NAD+ is typically linked to catabolic energy production, while NADPH is used in anabolic reactions and antioxidant defense. This dual specificity allows the enzyme to participate in both oxidative and reductive pathways, depending on the cellular redox state and metabolic demands.
Integration with the TCA Cycle and Anaplerosis
In simple terms: The product 2-oxoglutarate feeds into the energy-producing cycle.
By producing 2-oxoglutarate, the enzyme supports anaplerosis, replenishing TCA cycle intermediates that are consumed in biosynthesis. This is particularly important in tissues with high metabolic rates, such as the brain and liver. The interplay between glutamate dehydrogenase and other TCA cycle enzymes, such as malate dehydrogenase, ensures metabolic flexibility.
Regulation by Metabolites and Multienzyme Interactions
In simple terms: Other molecules can speed up or slow down the enzyme.
The activity of glutamate dehydrogenase can be modulated by metabolites such as citrate, alpha-ketoglutarate, and glutamate itself, as well as through interactions with other enzymes like malate dehydrogenase. These regulatory mechanisms allow the enzyme to respond to changes in energy status and biosynthetic demand.
Key Genes Involved in GO:0004353 L-glutamate dehydrogenase [NAD(P)+] activity
The following genes and proteins are directly or indirectly associated with L-glutamate dehydrogenase [NAD(P)+] activity (GO:0004353) and its metabolic context.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GLUD1 | Encodes mitochondrial glutamate dehydrogenase 1, a major enzyme with GO:0004353 activity | Central to nitrogen metabolism, hyperinsulinism/hyperammonemia syndrome, and neurotransmitter regulation |
| GLUD2 | Encodes a brain-specific glutamate dehydrogenase isoenzyme | Implicated in glutamate handling and neuroprotection |
| GOT1 | Aspartate aminotransferase, links glutamate and oxaloacetate metabolism | Provides alternative routes for glutamate utilization and TCA cycle anaplerosis |
| GOT2 | Mitochondrial aspartate aminotransferase | Coordinates with glutamate dehydrogenase in nitrogen shuttling |
| MDH1 | Malate dehydrogenase, interacts with glutamate dehydrogenase in multienzyme complexes | Regulates metabolic flux through TCA cycle and redox balance |
| MDH2 | Mitochondrial malate dehydrogenase | Supports TCA cycle and interacts with glutamate dehydrogenase |
| IDH1 | Isocitrate dehydrogenase, produces 2-oxoglutarate | Shares product with glutamate dehydrogenase and contributes to redox homeostasis |
| IDH2 | Mitochondrial isocitrate dehydrogenase | Generates 2-oxoglutarate and NADPH, intersecting with glutamate dehydrogenase pathways |
| GLS | Glutaminase, converts glutamine to glutamate | Supplies substrate for glutamate dehydrogenase |
| GLUL | Glutamine synthetase, converts glutamate to glutamine | Regulates glutamate availability and ammonia detoxification |
| SLC1A2 | Glutamate transporter in astrocytes | Controls extracellular glutamate levels and influences glutamate dehydrogenase substrate availability |
| SLC1A3 | Glutamate transporter | Regulates glutamate uptake and metabolism in glia |
| NOS1 | Neuronal nitric oxide synthase | Links glutamate signaling to oxidative stress and mitochondrial function |
| PARK2 | Parkin, involved in mitochondrial quality control | Mutations linked to Parkinson's disease and mitochondrial dysfunction |
| PINK1 | PTEN-induced kinase 1, mitochondrial kinase | Implicated in Parkinson's disease and mitochondrial homeostasis |
| mTOR | Serine/threonine kinase regulating cell growth | Modulates autophagy and metabolism in response to glutamate-induced stress |
| PIK3CA | PI3K catalytic subunit | Participates in PI3K/AKT/mTOR signaling activated by glutamate stress |
| AKT1 | Serine/threonine kinase | Mediates survival signaling downstream of PI3K and affects metabolism |
How Is L-glutamate dehydrogenase [NAD(P)+] activity Regulated?
The activity of L-glutamate dehydrogenase [NAD(P)+] is regulated at multiple levels. Allosterically, metabolites such as citrate, alpha-ketoglutarate, and glutamate can modulate enzyme activity, and interactions with malate dehydrogenase within multienzyme complexes influence flux. In the brain, astrocytic glutamate uptake and metabolism are tightly coupled to cerebral blood flow regulation, with glutamate dehydrogenase playing a role in this process. Signaling pathways such as PI3K/AKT/mTOR can affect cell survival and autophagy in response to glutamate-induced stress, indirectly influencing glutamate dehydrogenase function. Additionally, mitochondrial dysfunction associated with Parkinson's disease can impact the enzyme's activity through altered redox state and energy charge.
L-glutamate dehydrogenase [NAD(P)+] activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GLUD1 | Hyperinsulinism/hyperammonemia syndrome, metabolic dysregulation | Knockout or point-mutation cell models to study enzyme kinetics and ammonia handling |
| PARK2 | Parkinson's disease, mitochondrial dysfunction | Knockout dopaminergic neurons to assess glutamate dehydrogenase activity and redox balance |
| PINK1 | Parkinson's disease, mitophagy | Knockout cell lines to study mitochondrial quality control and glutamate metabolism |
| SLC1A2 | Glutamate excitotoxicity, neurovascular coupling | Overexpression or knockout astrocytes to measure glutamate uptake and dehydrogenase flux |
| mTOR | Autophagy regulation in neuronal stress | Knock-in reporter cells to monitor mTOR activity under glutamate stress |
Parkinson's Disease and Mitochondrial Dysfunction
Mitochondrial dysfunction is a hallmark of Parkinson's disease, and impaired glutamate dehydrogenase activity can contribute to altered glutamate metabolism and oxidative stress in dopaminergic neurons. The enzyme's role in maintaining redox balance and supplying TCA cycle intermediates makes it relevant to neurodegeneration.
Glutamate Excitotoxicity and Neuronal Injury
Excessive glutamate can trigger excitotoxicity, and enzymes that metabolize glutamate, including glutamate dehydrogenase, are critical for preventing neuronal damage. Enhanced NAD(P)H:quinone reductase activity has been shown to protect against glutamate toxicity, highlighting the importance of redox balance in this context. Neuronal preconditioning mechanisms also involve modulation of glutamate metabolism.
Autophagy and Cell Death in Neurons
Glutamate-induced autophagic cell death can be inhibited by activation of PI3K/AKT/mTOR signaling, and natural compounds like Selaginella tamariscina have been studied for their neuroprotective effects. Glutamate dehydrogenase activity may influence these pathways by altering glutamate and 2-oxoglutarate levels.
Metabolic Disorders and Hyperammonemia
Because glutamate dehydrogenase is central to ammonia detoxification and nitrogen balance, its dysfunction can lead to hyperammonemia and related metabolic disorders. The enzyme's ability to use NAD(P)+ links it to redox homeostasis and energy metabolism.
From L-glutamate dehydrogenase [NAD(P)+] activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of GLUD1 affect TCA cycle anaplerosis? | GLUD1 knockout cell line (e.g., HEK293 or HepG2) with metabolic profiling |
| How do point mutations in GLUD1 alter enzyme kinetics? | Point-mutation knock-in models expressing mutant GLUD1 |
| Can overexpression of GLUD2 protect neurons from glutamate toxicity? | Overexpression of GLUD2 in primary neurons or SH-SY5Y cells |
| What is the role of GLUD1 in astrocytic glutamate handling? | Astrocyte-specific knockout or tagged knock-in mice |
| How does GLUD1 activity influence autophagy under glutamate stress? | Knockout cells treated with glutamate and analyzed for LC3 and mTOR signaling |
| Does GLUD1 interact with MDH2 in multienzyme complexes? | Tagged knock-in of GLUD1 and MDH2 for co-immunoprecipitation |
How to Study the L-glutamate dehydrogenase [NAD(P)+] activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| NAD(P)H absorbance assay | Enzyme activity via NAD(P)H production | Kinetic characterization of GLUD1 mutants |
| 13C isotope tracing | Metabolic flux through TCA cycle and glutamate dehydrogenase | Quantifying anaplerosis in cancer or neuronal cells |
| RNA-seq | Transcriptional changes in response to GLUD1 manipulation | Identifying compensatory pathways |
| CRISPR library screening | Genes required for cell survival under glutamate stress | Discovering synthetic lethal targets |
| Fluorescent NAD(P)H sensors | Real-time redox changes | Live-cell imaging of neuronal metabolism |
| Co-immunoprecipitation | Protein-protein interactions | Studying multienzyme complexes with MDH |
| Seahorse respirometry | Mitochondrial respiration and glycolysis | Assessing metabolic phenotype of GLUD1 knockout cells |
| Western blot | Protein expression levels | Validating knockout or overexpression models |
Enzymatic Activity Assays
Direct measurement of L-glutamate dehydrogenase [NAD(P)+] activity can be performed using spectrophotometric assays that monitor the reduction of NAD(P)+ to NAD(P)H at 340 nm. These assays use L-glutamate as substrate and can be adapted to study kinetic parameters, cofactor preference, and inhibitor effects.
Metabolic Flux Analysis
Isotope tracing with 13C-labeled glutamate or glutamine can quantify flux through glutamate dehydrogenase and the TCA cycle. This approach reveals how the enzyme contributes to anaplerosis and redox balance in different cell types.
Genomic and Transcriptomic Profiling
RNA-seq and CRISPR screening can identify genes that regulate or compensate for glutamate dehydrogenase activity. Such studies help map the genetic network around GO:0004353 and uncover synthetic lethal interactions.
Imaging and Reporter Systems
Genetically encoded fluorescent sensors for NAD(P)H or 2-oxoglutarate can be used to monitor real-time changes in glutamate dehydrogenase activity in live cells. These tools are valuable for studying dynamic metabolic responses in neurons and astrocytes.
How CRISPR Can Be Used to Study GO:0004353 L-glutamate dehydrogenase [NAD(P)+] activity
Knockout
CRISPR knockout of GLUD1 or related genes can abolish L-glutamate dehydrogenase [NAD(P)+] activity, allowing researchers to study its role in nitrogen metabolism, TCA cycle anaplerosis, and cell survival. Knockout models are essential for identifying compensatory pathways and for validating drug targets.
Point Mutation
Introducing specific point mutations into GLUD1 via CRISPR base editing or homology-directed repair can mimic disease-associated variants or alter catalytic residues. These models help dissect the kinetic and regulatory consequences of individual amino acid changes.
Knock-in
Knock-in of tagged GLUD1 (e.g., FLAG or GFP) enables affinity purification, imaging, and interaction studies. Tagged knock-in models are valuable for tracking enzyme localization and complex formation in live cells.
Overexpression
CRISPR activation or lentiviral overexpression of GLUD1 or GLUD2 can increase enzyme levels, allowing researchers to study the effects of enhanced glutamate dehydrogenase activity on redox balance, autophagy, and neuroprotection.
How EDITGENE Supports L-glutamate dehydrogenase [NAD(P)+] activity Research
Researchers studying L-glutamate dehydrogenase [NAD(P)+] activity-related genes often need to determine whether a candidate gene is causally involved in metabolic regulation, neuroprotection, or disease progression. Precise genetic models are essential to move from correlation to causation.
Contact EDITGENE today to design your custom CRISPR model for L-glutamate dehydrogenase [NAD(P)+] activity research.
Frequently Asked Questions About L-glutamate dehydrogenase [NAD(P)+] activity
What is L-glutamate dehydrogenase [NAD(P)+] activity?
It is a molecular function defined by GO:0004353 that catalyzes the reversible conversion of L-glutamate to 2-oxoglutarate and ammonia, using NAD+ or NADP+ as a cofactor.
What genes are involved in L-glutamate dehydrogenase [NAD(P)+] activity?
The primary genes are GLUD1 and GLUD2, which encode glutamate dehydrogenase isoenzymes. Other related genes include GOT1, GOT2, MDH1, MDH2, and IDH1/2, which participate in connected metabolic pathways.
What is the reaction catalyzed by GO:0004353?
The reaction is: L-glutamate + NAD(P)+ + H2O = 2-oxoglutarate + NH4+ + NAD(P)H + H+.
Why is glutamate dehydrogenase important in the brain?
It helps regulate glutamate levels, supports astrocytic control of cerebral blood flow, and protects against excitotoxicity by metabolizing excess glutamate.
How is L-glutamate dehydrogenase activity measured?
It is commonly measured using spectrophotometric assays that monitor NAD(P)H production at 340 nm, or by isotope tracing and fluorescent sensors.
What diseases are associated with glutamate dehydrogenase dysfunction?
Dysfunction has been linked to Parkinson's disease, hyperammonemia, hyperinsulinism, and glutamate-induced excitotoxicity.
Can CRISPR be used to study GO:0004353?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of GLUD1 and related genes to study their function.
What is the role of NAD(P)+ in this activity?
NAD(P)+ acts as an electron acceptor, being reduced to NAD(P)H during the oxidative deamination of glutamate. The dual specificity for NAD+ and NADP+ allows the enzyme to participate in both catabolic and anabolic processes.
How does glutamate dehydrogenase interact with the TCA cycle?
It produces 2-oxoglutarate, a TCA cycle intermediate, thereby supporting anaplerosis and energy production.
What model systems are used to study L-glutamate dehydrogenase [NAD(P)+] activity?
Common models include knockout cell lines, primary neurons, astrocytes, and animal models, often combined with metabolic assays and imaging.
Conclusion
GO:0004353, L-glutamate dehydrogenase [NAD(P)+] activity, represents a critical metabolic function that bridges amino acid catabolism, TCA cycle anaplerosis, and redox homeostasis. Its roles in nitrogen handling, neurotransmission, and mitochondrial function make it relevant to neurodegenerative diseases, metabolic disorders, and cancer. Advances in CRISPR-based genome editing and metabolic profiling now enable precise interrogation of this activity in physiologically relevant models. Continued research into the regulation and genetic control of glutamate dehydrogenase will likely yield new insights into disease mechanisms and therapeutic opportunities.
References
- 1. Greenamyre JT et al.. 1999. Mitochondrial dysfunction in Parkinson's disease.. Biochem Soc Symp 66:85-97 PMID: 10989660
- 2. Akita H et al.. 2020. Identification and functional characterization of NAD(P)(+) -dependent meso-diaminopimelate dehydrogenase from Numidum massiliense.. Microbiologyopen 9(8):e1059 PMID: 32485072
- 3. Hou Y et al.. 2011. Alpha-Ketoglutarate and intestinal function.. Front Biosci (Landmark Ed) 16(3):1186-96 PMID: 21196226
- 4. Fahien LA et al.. 1988. Regulation of malate dehydrogenase activity by glutamate, citrate, alpha-ketoglutarate, and multienzyme interaction.. J Biol Chem 263(22):10687-97 PMID: 2899080
- 5. Murphy TH et al.. 1991. Enhanced NAD(P)H:quinone reductase activity prevents glutamate toxicity produced by oxidative stress.. J Neurochem 56(3):990-5 PMID: 1704427
- 6. Gáspár T et al.. 2009. Immediate neuronal preconditioning by NS1619.. Brain Res 1285:196-207 PMID: 19523929
- 7. Koehler RC et al.. 2009. Astrocytes and the regulation of cerebral blood flow.. Trends Neurosci 32(3):160-9 PMID: 19162338
- 8. Jeong YH et al.. 2022. Selaginella tamariscina Inhibits Glutamate-Induced Autophagic Cell Death by Activating the PI3K/AKT/mTOR Signaling Pathways.. Int J Mol Sci 23(19) PMID: 36232743
